Langerhans cell histiocytosis (LCH) is an inflammatory neoplasia of myeloid precursor cells driven by mutations in the mitogen-activated protein kinase pathway.[1] While LCH can involve any organ individually or concurrently, the bones and the skin are the most affected. The gene discussed is WNK2; the disease is Langerhans cell histiocytosis.